BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22282593)

  • 1. Basic and translational concepts of immune-mediated glomerular diseases.
    Couser WG
    J Am Soc Nephrol; 2012 Mar; 23(3):381-99. PubMed ID: 22282593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis of immune glomerulonephritis].
    Rougier JP; Ronco P
    Rev Prat; 2003 Nov; 53(18):1998-2004. PubMed ID: 15008213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases.
    Kambham N
    Adv Anat Pathol; 2012 Mar; 19(2):111-24. PubMed ID: 22313839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the immunopathogenesis of glomerular disease.
    Dickinson BL
    Clin Immunol; 2016 Aug; 169():89-97. PubMed ID: 27373970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells in crescentic glomerulonephritis.
    Tipping PG; Holdsworth SR
    J Am Soc Nephrol; 2006 May; 17(5):1253-63. PubMed ID: 16624930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histological classification of chronic glomerular diseases].
    Noël LH; Gubler MC
    Rev Prat; 2003 Nov; 53(18):2005-12. PubMed ID: 15008214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and treatment of glomerulonephritis-an update.
    Couser WG
    J Bras Nefrol; 2016 Mar; 38(1):107-22. PubMed ID: 27049372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and its role in innate and adaptive immune responses.
    Dunkelberger JR; Song WC
    Cell Res; 2010 Jan; 20(1):34-50. PubMed ID: 20010915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of glomerulonephritis.
    Couser WG
    Kidney Int Suppl; 1993 Jul; 42():S19-26. PubMed ID: 8361123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.
    Kitching AR; Turner AL; Wilson GR; Edgtton KL; Tipping PG; Holdsworth SR
    J Am Soc Nephrol; 2004 Sep; 15(9):2373-82. PubMed ID: 15339986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis.
    Meyer-Schwesinger C; Dehde S; Klug P; Becker JU; Mathey S; Arefi K; Balabanov S; Venz S; Endlich KH; Pekna M; Gessner JE; Thaiss F; Meyer TN
    J Immunol; 2011 Sep; 187(6):3218-29. PubMed ID: 21844386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulonephritis, Th1 and Th2: what's new?
    Tipping PG; Kitching AR
    Clin Exp Immunol; 2005 Nov; 142(2):207-15. PubMed ID: 16232206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
    Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells and damage-associated molecular patterns: endogenous danger signals linking innate and adaptive immunity.
    Nace G; Evankovich J; Eid R; Tsung A
    J Innate Immun; 2012; 4(1):6-15. PubMed ID: 22086146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis.
    Holdsworth SR; Neale TJ
    Lab Invest; 1984 Aug; 51(2):172-80. PubMed ID: 6611452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immune-deposit formation and the mediation of immune renal injury.
    Nangaku M; Couser WG
    Clin Exp Nephrol; 2005 Sep; 9(3):183-91. PubMed ID: 16189625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.
    Harizi H; Gualde N
    Tissue Antigens; 2005 Jun; 65(6):507-14. PubMed ID: 15896197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.